Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

Late pregnancy helps repair brain damage in rats due to the GABAergic system.

Better-designed, long-term studies are needed to optimize treatment for trichotillomania and trichophagia.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Bariatric surgery affects skin health, causing both direct complications and changes in existing skin conditions, often related to nutritional deficiencies.

Red spots on fingertips can be a sign of a skin condition linked to gluten sensitivity, treatable with a gluten-free diet.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Oral zinc sulphate reduces dark hair color in mice.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Personality traits and anxiety affect hair loss patients' quality of life.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride for hair loss may cause gynecomastia; doctors should inform patients.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Immune cells affect hair growth and could lead to new hair loss treatments.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

Diphencyprone helped most patients with alopecia areata regrow some hair.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.